학술논문
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Document Type
Article
Author
Østergaard, M.; Hetland, M.L.; Ørnbjerg, L.M.; Van Vollenhoven, R.F.; Rudin, A.; Gjertsson, I.; Heiberg, M.S.; Uhlig, T.; Haavardsholm, E.A.; Nordström, D.C.; Parmanne, P.; Nurmohamed, M.T.; Gudbjornsson, B.; Grondal, G.; Bøyesen, P.; Lend, K.; Lindqvist, J.; Faustini, F.; Lampa, J.; Hørslev-Petersen, K.; Hendricks, O.; Sokka, T.; Rannio, T.; Krabbe, S.; Glinatsi, D.; Kapetanovic, M.C.; Giovanni, C.; Aga, A.-B.; Lorenzen, T.; Back, J.; Vedder, D.; Grenholm, E.; Ljoså, M.K.; Brodin, E.; Lindegaard, H.; Söderbergh, A.; Rizk, M.; Kastbom, A.; Larsson, P.; Uhrenholt, L.; Just, Sø.A.; Stevens, D.J.; Bay Laurbjerg, T.; Bakland, G.; Olsen, I.C.
Source
In: Annals of the Rheumatic Diseases . (Annals of the Rheumatic Diseases, 2023)
Subject
Language
English
ISSN
14682060
00034967
00034967